Creative Medical Technology Holdings (Creative Medical Technology Holdings) Cash, Cash Equivalents, Marketable Securities : $9.99 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Cash, Cash Equivalents, Marketable Securities?

Creative Medical Technology Holdings's quarterly cash, cash equivalents, marketable securities declined from Jun. 2023 ($13.57 Mil) to Sep. 2023 ($11.97 Mil) but then stayed the same from Sep. 2023 ($11.97 Mil) to Dec. 2023 ($9.99 Mil).

Creative Medical Technology Holdings's annual cash, cash equivalents, marketable securities increased from Dec. 2021 ($10.72 Mil) to Dec. 2022 ($18.40 Mil) but then declined from Dec. 2022 ($18.40 Mil) to Dec. 2023 ($9.99 Mil).

Creative Medical Technology Holdings Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Creative Medical Technology Holdings's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Cash, Cash Equivalents, Marketable Securities Chart

Creative Medical Technology Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

0.09

0.10

10.72

18.40

9.99

Creative Medical Technology Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															18.40	14.56	13.57	11.97	9.99

Creative Medical Technology Holdings Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Creative Medical Technology Holdings (NAS:CELZ) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Creative Medical Technology Holdings Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

211 E Osborn Road, Phoenix, AZ, USA, 85012

Website

https://www.creativemedicaltechnology.com

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Executives

Timothy Warbington	director, 10 percent owner, officer: President & CEO	211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger	director	1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow	director	26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang	director	5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim	director	211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc.	10 percent owner	211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst	10 percent owner	2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel	director	1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson	director, officer: CFO & Sr.VP	822 VERA STREET, SOLANA BEACH CA 92075
Steven L White	director, officer: President,Secretary,Treasurer	386 NORTH 210 EAST, MAPLETON UT 84664